Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 34581 | 109 | 19.0 | 43% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 5 | 4 | CHEMISTRY, ORGANIC//CHEMISTRY, INORGANIC & NUCLEAR//CHEMISTRY, MULTIDISCIPLINARY | 1745167 |
| 346 | 3 | CARDIOTOXICITY//ANTHRACYCLINES//CAMPTOTHECIN | 36072 |
| 2252 | 2 | ANGUCYCLINE//IDARUBICIN//ANGUCYCLINONE | 4694 |
| 34581 | 1 | MENOGARIL//DNA UNWINDING ACTIVITY//N O O TRIANGULAR PHARMACOPHORE | 109 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | MENOGARIL | authKW | 3520051 | 16% | 74% | 17 |
| 2 | DNA UNWINDING ACTIVITY | authKW | 280143 | 1% | 100% | 1 |
| 3 | N O O TRIANGULAR PHARMACOPHORE | authKW | 280143 | 1% | 100% | 1 |
| 4 | PEDIATDANA FARBER CANC CHILDRENS HOSP | address | 280143 | 1% | 100% | 1 |
| 5 | PHASE II AML | authKW | 280143 | 1% | 100% | 1 |
| 6 | PHASE II MENOGARIL ASTROCYTOMA | authKW | 280143 | 1% | 100% | 1 |
| 7 | ACIDIC PATCH | authKW | 93380 | 1% | 33% | 1 |
| 8 | ILLINOIS CANC | address | 93380 | 1% | 33% | 1 |
| 9 | STOMACH CANCERS | authKW | 93380 | 1% | 33% | 1 |
| 10 | LATENCY ASSOCIATED NUCLEAR ANTIGEN LANA | authKW | 56027 | 1% | 20% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Oncology | 1622 | 62% | 0% | 68 |
| 2 | Pharmacology & Pharmacy | 390 | 36% | 0% | 39 |
| 3 | Biophysics | 44 | 8% | 0% | 9 |
| 4 | CYTOLOGY & HISTOLOGY | 35 | 1% | 0% | 1 |
| 5 | Chemistry, Medicinal | 18 | 5% | 0% | 5 |
| 6 | Toxicology | 18 | 5% | 0% | 5 |
| 7 | Biochemistry & Molecular Biology | 8 | 12% | 0% | 13 |
| 8 | Biology | 6 | 3% | 0% | 3 |
| 9 | Multidisciplinary Sciences | 2 | 1% | 0% | 1 |
| 10 | Medicine, Research & Experimental | 0 | 2% | 0% | 2 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | PEDIATDANA FARBER CANC CHILDRENS HOSP | 280143 | 1% | 100% | 1 |
| 2 | ILLINOIS CANC | 93380 | 1% | 33% | 1 |
| 3 | PEDIAT ONCOL HEMATOL ONCOL | 40019 | 1% | 14% | 1 |
| 4 | LNBIO | 7780 | 1% | 3% | 1 |
| 5 | CHEM BIODYNAM | 5834 | 1% | 2% | 1 |
| 6 | SCI THER EUT | 4179 | 1% | 1% | 1 |
| 7 | NACL BIOCIENCIAS | 3043 | 1% | 1% | 1 |
| 8 | OPERAT OFF | 2239 | 1% | 1% | 1 |
| 9 | ROBERT H LURIE CANC | 1277 | 1% | 0% | 1 |
| 10 | BARBARA ANN KARMANOS CANC | 300 | 1% | 0% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | INVESTIGATIONAL NEW DRUGS | 31753 | 16% | 1% | 17 |
| 2 | SELECTIVE CANCER THERAPEUTICS | 4591 | 1% | 2% | 1 |
| 3 | CANCER TREATMENT REPORTS | 4572 | 6% | 0% | 6 |
| 4 | EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 3715 | 5% | 0% | 5 |
| 5 | INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS | 1746 | 4% | 0% | 4 |
| 6 | CHEMICO-BIOLOGICAL INTERACTIONS | 1234 | 5% | 0% | 5 |
| 7 | CANCER RESEARCH | 1208 | 12% | 0% | 13 |
| 8 | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1108 | 4% | 0% | 4 |
| 9 | BASIC AND APPLIED HISTOCHEMISTRY | 817 | 1% | 0% | 1 |
| 10 | ANTIBIOTIKI I MEDITSINSKAYA BIOTEKHNOLOGIYA | 724 | 1% | 0% | 1 |
Author Key Words |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | MENOGARIL | 3520051 | 16% | 74% | 17 | Search MENOGARIL | Search MENOGARIL |
| 2 | DNA UNWINDING ACTIVITY | 280143 | 1% | 100% | 1 | Search DNA+UNWINDING+ACTIVITY | Search DNA+UNWINDING+ACTIVITY |
| 3 | N O O TRIANGULAR PHARMACOPHORE | 280143 | 1% | 100% | 1 | Search N+O+O+TRIANGULAR+PHARMACOPHORE | Search N+O+O+TRIANGULAR+PHARMACOPHORE |
| 4 | PHASE II AML | 280143 | 1% | 100% | 1 | Search PHASE+II+AML | Search PHASE+II+AML |
| 5 | PHASE II MENOGARIL ASTROCYTOMA | 280143 | 1% | 100% | 1 | Search PHASE+II+MENOGARIL+ASTROCYTOMA | Search PHASE+II+MENOGARIL+ASTROCYTOMA |
| 6 | ACIDIC PATCH | 93380 | 1% | 33% | 1 | Search ACIDIC+PATCH | Search ACIDIC+PATCH |
| 7 | STOMACH CANCERS | 93380 | 1% | 33% | 1 | Search STOMACH+CANCERS | Search STOMACH+CANCERS |
| 8 | LATENCY ASSOCIATED NUCLEAR ANTIGEN LANA | 56027 | 1% | 20% | 1 | Search LATENCY+ASSOCIATED+NUCLEAR+ANTIGEN+LANA | Search LATENCY+ASSOCIATED+NUCLEAR+ANTIGEN+LANA |
| 9 | SOUTHWEST ONCOLOGY GROUP | 21548 | 1% | 8% | 1 | Search SOUTHWEST+ONCOLOGY+GROUP | Search SOUTHWEST+ONCOLOGY+GROUP |
| 10 | ANTHRACYCLINONES | 20008 | 1% | 7% | 1 | Search ANTHRACYCLINONES | Search ANTHRACYCLINONES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | LI, LH , KRUEGER, WC , (1991) THE BIOCHEMICAL PHARMACOLOGY OF NOGALAMYCIN AND ITS DERIVATIVES.PHARMACOLOGY & THERAPEUTICS. VOL. 51. ISSUE 2. P. 239-255 | 43 | 67% | 10 |
| 2 | MAZUREK, C , DUTCHER, JP , SCHWARTZ, EL , GARL, S , BENSON, L , WIERNIK, PH , (1993) PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF MENOGARIL (7-CON-O-METHYLNOGAROL) IN PREVIOUSLY TREATED PATIENTS WITH ACUTE-LEUKEMIA.INVESTIGATIONAL NEW DRUGS. VOL. 11. ISSUE 4. P. 313-322 | 19 | 95% | 3 |
| 3 | INABA, M , SATO, S , YAMORI, T , TASHIRO, T , OHNISHI, Y , MARUO, K , UEYAMA, Y , TSURUO, T , (1992) ANTICANCER ACTIVITIES OF ORALLY-ADMINISTERED MENOGARIL AGAINST HUMAN STOMACH AND BREAST CANCERS IMPLANTED IN NUDE-MICE.ANTICANCER RESEARCH. VOL. 12. ISSUE 6B. P. 1953-1956 | 16 | 89% | 8 |
| 4 | KUCUK, O , KILTON, L , WADE, JL , BLOUGH, R , BENSON, AB , (2000) PHASE II TRIAL OF MENOGARIL IN PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA OR CHRONIC LYMPHOCYTIC LEUKEMIA.AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. VOL. 23. ISSUE 4. P. 379-383 | 10 | 91% | 1 |
| 5 | ADAMS, WJ , MCGOVREN, JP , DALM, EA , BREWER, JE , HOSLEY, JD , (1989) PHARMACOKINETICS AND SYSTEMIC BIOAVAILABILITY OF MENOGARIL, AN ANTHRACYCLINE ANTITUMOR AGENT, IN THE MOUSE, DOG, AND MONKEY.CANCER RESEARCH. VOL. 49. ISSUE 22. P. 6328-6336 | 16 | 76% | 5 |
| 6 | WEISS, GR , BROWN, TD , KUHN, JG , VONHOFF, DD , EARHART, RH , ADAMS, WJ , BREWER, JE , HOSLEY, JD , KASUNIC, DA , (1993) A PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF THE ORAL AND THE ORAL INTRAVENOUS ADMINISTRATION OF MENOGARIL.INVESTIGATIONAL NEW DRUGS. VOL. 11. ISSUE 1. P. 17-27 | 9 | 90% | 5 |
| 7 | STEWART, DJ , GREWAAL, D , GREEN, RM , GOEL, R , MIKHAEL, N , MONTPETIT, VAJ , REDMOND, D , EARHART, R , (1993) HUMAN AUTOPSY-TISSUE DISTRIBUTION OF MENOGARIL AND ITS METABOLITES.CANCER CHEMOTHERAPY AND PHARMACOLOGY. VOL. 32. ISSUE 5. P. 373-378 | 11 | 55% | 3 |
| 8 | MCGOVREN, JP , NELSON, KG , LASSUS, M , CRADOCK, JC , PLOWMAN, J , CHRISTOPHER, JP , (1984) MENOGARIL - A NEW ANTHRACYCLINE AGENT ENTERING CLINICAL-TRIALS.INVESTIGATIONAL NEW DRUGS. VOL. 2. ISSUE 4. P. 359-367 | 10 | 91% | 36 |
| 9 | YOSHIDA, M , KOBUNAI, T , NAKANO, K , SAITO, H , TOKO, T , TAKEDA, S , UNEMI, N , (1996) PREDICTION OF THE OPTIMUM CLINICAL DOSING SCHEDULE FOR MENOGARIL FROM RESULTS WITH TUMOR-BEARING MICE.ANTICANCER RESEARCH. VOL. 16. ISSUE 5A. P. 2869-2873 | 8 | 62% | 0 |
| 10 | DUTCHER, JP , LEONG, T , MAKARY, AZ , BENNETT, J , FRONTIERA, M , MILLER, H , WIERNIK, PH , (1995) A PHASE-II STUDY OF MENOGARIL (7R-O-METHYLNOGAROL) IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID-LEUKEMIA - A STUDY OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP.LEUKEMIA. VOL. 9. ISSUE 10. P. 1638-1642 | 7 | 70% | 7 |
Classes with closest relation at Level 1 |